These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36321906)

  • 21. Dissemination of carbapenemase-producing Enterobacterales in the community of Rawalpindi, Pakistan.
    Habib A; Lo S; Villageois-Tran K; Petitjean M; Malik SA; Armand-Lefèvre L; Ruppé E; Zahra R
    PLoS One; 2022; 17(7):e0270707. PubMed ID: 35802735
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Monitoring of hospital sewage shows both promise and limitations as an early-warning system for carbapenemase-producing Enterobacterales in a low-prevalence setting.
    Flach CF; Hutinel M; Razavi M; Åhrén C; Larsson DGJ
    Water Res; 2021 Jul; 200():117261. PubMed ID: 34082263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term contamination of sink drains by carbapenemase-producing Enterobacterales in three intensive care units: characteristics and transmission to patients.
    Lemarié C; Legeay C; Mahieu R; Moal F; Ramont C; Kouatchet A; Eveillard M
    J Hosp Infect; 2021 Jun; 112():16-20. PubMed ID: 33636255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating NG-Test CARBA 5 Multiplex Immunochromatographic and Cepheid Xpert CARBA-R Assays among Carbapenem-Resistant
    Huang YT; Kuo YW; Lee NY; Tien N; Liao CH; Teng LJ; Ko WC; Hsueh PR;
    Microbiol Spectr; 2022 Feb; 10(1):e0172821. PubMed ID: 35019772
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Implementation of contact isolation strategy for the containment of extended-spectrum β-lactamase carriers in a University Hospital positively affects the epidemiology of carbapenemase-producing Enterobacterales.
    Hernández-García M; Díaz-Agero C; Pérez-Viso B; Sánchez AM; López-Fresneña N; Morosini MI; Ruiz-Garbajosa P; Cantón R
    Enferm Infecc Microbiol Clin (Engl Ed); 2021 Nov; 39(9):429-435. PubMed ID: 34736747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genomic and clinical characterisation of multidrug-resistant carbapenemase-producing ST231 and ST16 Klebsiella pneumoniae isolates colonising patients at Siriraj hospital, Bangkok, Thailand from 2015 to 2017.
    Boonyasiri A; Jauneikaite E; Brinkac LM; Greco C; Lerdlamyong K; Tangkoskul T; Nguyen K; Thamlikitkul V; Fouts DE
    BMC Infect Dis; 2021 Feb; 21(1):142. PubMed ID: 33541274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Universal hospital admission screening for carbapenemase-producing organisms in a low-prevalence setting.
    Otter JA; Dyakova E; Bisnauthsing KN; Querol-Rubiera A; Patel A; Ahanonu C; Tosas Auguet O; Edgeworth JD; Goldenberg SD
    J Antimicrob Chemother; 2016 Dec; 71(12):3556-3561. PubMed ID: 27516471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time-series modelling for the quantification of seasonality and forecasting antibiotic-resistant episodes: application to carbapenemase-producing Enterobacteriaceae episodes in France over 2010-20.
    Roux J; Nekkab N; Colomb-Cotinat M; Astagneau P; Crépey P
    J Antimicrob Chemother; 2021 Jan; 76(1):226-232. PubMed ID: 32929455
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fecal Carriage and Molecular Characterization of Carbapenemase-Producing
    Pérez-López A; Sundararaju S; Tsui KM; Al-Mana H; Hasan MR; Suleiman M; Al Maslamani E; Imam O; Roscoe D; Tang P
    Microbiol Spectr; 2021 Dec; 9(3):e0112221. PubMed ID: 34756089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology and risk factors for carbapenemase-producing Enterobacteriaceae carriage in the hospital: A population-based nested case-control study.
    Fan M; Wong SC; Yu Q; Li PH; Wu P; Chan EWY; Wong ICK; Tun HM; Cowling BJ; Cheng VC; Chui CSL
    J Glob Antimicrob Resist; 2023 Jun; 33():242-248. PubMed ID: 37086890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dynamics of carbapenemase-producing Enterobacterales intestinal colonisation in the elderly population after hospital discharge, Italy, 2018-2020.
    Tinelli M; Rossini A; Scudeller L; Zabzuni D; Errico G; Fogato E; D'Angelo R; Gentiloni Silverj F; Cesana E; Bergamaschini LC; Pasi F; Monaco M; Cerquetti M; Pantosti A; Giufrè M
    Int J Antimicrob Agents; 2022 Jun; 59(6):106594. PubMed ID: 35483624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antecedent Carbapenem Exposure as a Risk Factor for Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae and Carbapenemase-Producing Enterobacteriaceae.
    Marimuthu K; Ng OT; Cherng BPZ; Fong RKC; Pada SK; De PP; Ooi ST; Smitasin N; Thoon KC; Krishnan PU; Ang MLT; Chan DSG; Kwa ALH; Deepak RN; Chan YK; Chan YFZ; Huan X; Zaw Linn K; Tee NWS; Tan TY; Koh TH; Lin RTP; Hsu LY; Sengupta S; Paterson DL; Perencevich E; Harbarth S; Teo J; Venkatachalam I;
    Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Integrating rapid diagnostics in Gram-negative bloodstream infections of patients colonized by carbapenemase-producing Enterobacterales.
    Bianco G; Boattini M; Iannaccone M; Pastrone L; Bondi A; Peradotto M; Cavallo R; Costa C
    J Hosp Infect; 2021 Apr; 110():84-88. PubMed ID: 33539936
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of carbapenemase-producing Enterobacteriaceae from colonized patients in a university hospital in Madrid, Spain, during the R-GNOSIS project depicts increased clonal diversity over time with maintenance of high-risk clones.
    Hernández-García M; Pérez-Viso B; Carmen Turrientes M; Díaz-Agero C; López-Fresneña N; Bonten M; Malhotra-Kumar S; Ruiz-Garbajosa P; Cantón R
    J Antimicrob Chemother; 2018 Nov; 73(11):3039-3043. PubMed ID: 30053018
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nutritional drinks and enteral feeds promote the growth of carbapenemase-producing Enterobacterales in conditions that simulate disposal in hospital sinks.
    Kearney A; Humphreys H; Fitzgerald-Hughes D
    J Hosp Infect; 2023 Sep; 139():74-81. PubMed ID: 37271316
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duration of Carbapenemase-Producing Enterobacteriaceae Carriage in Hospital Patients.
    Mo Y; Hernandez-Koutoucheva A; Musicha P; Bertrand D; Lye D; Ng OT; Fenlon SN; Chen SL; Ling ML; Tang WY; Barkham T; Nagarajan N; Cooper BS; Marimuthu K
    Emerg Infect Dis; 2020 Sep; 26(9):2182-2185. PubMed ID: 32818397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Multicentre evaluation of the Check-Direct CPE® assay for direct screening of carbapenemase-producing Enterobacteriaceae from rectal swabs.
    Huang TD; Bogaerts P; Ghilani E; Heinrichs A; Gavage P; Roisin S; Willems E; Verbruggen AM; Francart H; Denis O; Senterre JM; Glupczynski Y
    J Antimicrob Chemother; 2015; 70(6):1669-73. PubMed ID: 25637518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Institutional Burden of Carbapenemase-Producing Enterobacterales: The Effect of Changes in Surveillance Culture Methodology.
    Yavor A; Ben-Zvi H; Freeman S; Geffen Y; Adler A
    Microb Drug Resist; 2020 Nov; 26(11):1350-1356. PubMed ID: 32380896
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factors for carbapenem-resistant Enterobacteriaceae infections: a French case-control-control study.
    Nicolas-Chanoine MH; Vigan M; Laouénan C; Robert J;
    Eur J Clin Microbiol Infect Dis; 2019 Feb; 38(2):383-393. PubMed ID: 30488368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriaceae.
    Hayakawa K; Nakano R; Hase R; Shimatani M; Kato H; Hasumi J; Doi A; Sekiya N; Nei T; Okinaka K; Kasahara K; Kurai H; Nagashima M; Miyoshi-Akiyama T; Kakuta R; Yano H; Ohmagari N
    J Antimicrob Chemother; 2020 Mar; 75(3):697-708. PubMed ID: 31789374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.